医学
临床试验
萎缩
重症监护医学
临床药理学
混淆
间充质干细胞
药理学
神经科学
病理
心理学
作者
Niall Quinn,Roger A. Barker,Gregor K. Wenning
标识
DOI:10.1038/sj.clpt.6100454
摘要
Scientists and patients are keen to apply new experimental techniques to human diseases, especially currently untreatable progressive neurodegenerative diseases, of which multiple system atrophy (MSA) is an example. We argue that it behooves us to first have robust preclinical experimental evidence before launching into such studies in humans, and to control as much as possible for confounding effects when such trials come to be performed.
科研通智能强力驱动
Strongly Powered by AbleSci AI